ArticleGynecologic oncology2016

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.

Matthew F Buas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.